BLOG

Altasciences helped a client develop a robust preclinical formulation prototype at the maximum potency for their API BSC Class II compound.

Altasciences supported a client with HAP studies for the development of a novel analgesic, mirogabalin, currently marked in Japan, Korea, Taiwan, and China.

Issue 33 of The Altascientist investigates the benefits of integrated drug development solutions for the ever-increasing world of CNS therapeutics.

Altasciences’ interns reflect on their experience and what they’ve learned.

Representation and inclusion of various minority groups is crucial for medical research. Discover how drug developers, researchers, and regulators are ensuring this happens.

Discover 10 more essential life science resources, including expert insights, tips, case studies, webinars, podcasts, posters, scientific publications, videos, and more, that you may have missed from us!

Issue 38 of The Altascientist explores the key considerations for successful formulation development and manufacture for safety assessment, alongside examining the strategies Altasciences employs to support you in planning your program. Read or listen!